BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Business

  LifeArc Appointments Strengthen Board of Trustees

  LifeArc has strengthened its board by appointing three new trustees: Aisling Burnand, MBE, Chief Executive of the AMRC; Daniel Morgan; and Jessica Mann, Company Head, Cardiovascular Development Consulting, GmbH.

  December 5, 2017

   · 

  1 min read
• Business

  Probiodrug and Crossbeta Biosciences Extend Their Strategic Partnership in the Field of Alzheimer’s Disease Biomarkers

  The companies first established the partnership in 2016.

  December 5, 2017

   · 

  5 min read
• Drug Development

  Triphase Accelerator to Present Investigational New Drug Enabling Data for TRPH-222

  Triphase announced that its preclinical abstract describing TRPH-222, has been accepted by the American Society of Hematology as a poster presentation at the 59th ASH Annual Meeting & Exposition.

  December 5, 2017

   · 

  5 min read
• Business

  Immunovaccine to Hold Webcast and Conference Call to Discuss Clinical Data From Its Collaborative Combination Immunotherapy Trial in Advanced Ovarian Cancer

  The purpose of this conference call is to share top-line clinical data from its ongoing Phase 1b trial evaluating the safety and efficacy of Immunovaccine’s lead immuno-oncology candidate.

  December 5, 2017

   · 

  2 min read
• Drug Development

  LAM Therapeutics Announces Progress of its Clinical Portfolio with FDA Clearance of New Trial in Leukemia and Advancement of Clinical Trial in Lymphoma

  LAM Therapeutics advanced its clinical portfolio with the FDA clearance of LAM’s IND application for LAM-003 in leukemia patients.

  December 5, 2017

   · 

  3 min read
• Biotech Bay

  Frost & Sullivan Industry Experts Host Interactive Briefing Discussing the Technologies Driving Cancer, Diabetes and Obesity Management

  The webinar will offer expert insight from Frost & Sullivan’s Vandana Iyer.

  December 5, 2017

   · 

  2 min read
• Biotech Bay

  Light Polymers Announces Next-Generation OLED Polarizer Technology

  Light Polymers is announcing a next-generation circular polarizer for OLED displays based on lyotropic liquid crystal technology. Light Polymers’ proprietary nanochemistry creates a circular polarizer at 45 µm, thinner than any competitive offering.

  December 5, 2017

   · 

  2 min read
• Drug Development

  Galectin Therapeutics to Present Results From Phase IIb NASH-CX Trial on December 5, 2017

  The company will host a conference call and webcast, including a slide presentation, beginning at 8:30 a.m. ET on December 5, 2017.

  December 5, 2017

   · 

  2 min read
• Genmab to Hold 2017 R&D Update

  The meeting will include updates on daratumumab, including presentations by key opinion leaders on data from daratumumab studies presented at the 59th Annual Meeting of the American Society of Hematology (ASH).

  December 5, 2017

   · 

  4 min read
• Drug Development

  Novo Nordisk Receives FDA Approval of OZEMPIC (semaglutide) Injection for the Treatment of Adults With Type 2 Diabetes

  The approval of OZEMPIC is based on the results from a Phase 3a clinical trial program.

  December 5, 2017

   · 

  8 min read